TickerFactsScreenerDevelopers

Beam Therapeutics Inc. (BEAM) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$72.00M2020: -$95.74M2021: -$66.27M2022: $22.53M2023: -$149.19M2024: -$347.25M2025: -$345.10M-$345.10M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$345.10M+0.6%
2024-$347.25M-132.7%
2023-$149.19M-762.3%
2022$22.53M+134.0%
2021-$66.27M+30.8%
2020-$95.74M-33.0%
2019-$72.00M—